Field Trip is a company that offers psychedelic therapies. It has several locations (US/CA) that provides ketamine-assisted therapy. It has raised $19.5M in Series A & B funding rounds.
In March 2021, Field Trip announced it closed a bought deal short form prospectus offering at a value of $76 million.
Field Trip
“Field Trip Health is a new kind of mental wellness company. We offer a deeply human experience that combines the science of psychedelic medicine with personal psychotherapy and wellness practices. Our doctors and therapists are disrupting the mental health landscape and redefining the way we approach depression and mental health issues.”
The company is working on a variety of different arms related to psychedelics. This included a clinic, app, and original research. The latter is now working on FT-104, a patentable molecule (phase I planned in Q3 2021). By developing a new molecule, they may be able to sidestep the legal hassles associated with (known) psychedelics. In a mini-interview with Psilocybin Alpha, the company says the drug will have a half-life of 1/3rd (so about 1,5-2 hours) compared to psilocybin and can be administered orally or via injection.
Since October 2020 the company is listed on the Canadian Securities Exchange (CSE). The company was also funded (in part) by Synaptic Ventures.
Field Trip also hosts a podcast about psychedelics, named Field Tripping.
Heroic Hearts has partnered with Field Trip to raise awareness and provide insurance-covered ketamine treatment at Field Trips clinics.
They recently also launched an app to be used during a trip, called trip.
Key Staff
- Joseph del Moral – Founder & CEO
- Ronan Levy – Founder & Executive Chairman
- Hannan Fleiman – Founder & President of Healthcare Practice
- Mujeeb Jaffeir – Founder & President
- Ryan Yermus – Founder & Chief Clinical Officer
- Nathan Bryson – CSO
- Amardeep Manhas – CTO
- Andrew Weil – advisor
News
- Field Trip Health Ltd. Announces Participation in a MAPS-sponsored Multi-Site Study of MDMA-Assisted Therapy to Treat Eating Disorders (press release, January 2021)
- Field Trip Health Ltd. and WHOOP announce partnership to measure effect of psychedelic therapies on physiology and mental health (press release, November 2020)
- Field Trip Health Ltd. Prepares to Enter Oregon Market following the Passage of Measure 109 in Oregon, Creating the First Legal Market for Psilocybin Services (press release, November 2020)
- Field Trip Health Ltd. Provides Update on FT-104, Its Next Generation Psychedelic Molecule in Development (Psilocybin Alpha, October 2020)
- Field Trip Health Ltd. Continues Expansion With Psychedelic-Enhanced Therapy Center in Chicago (press release, October 2020)
- Heroic Hearts Project and Field Trip Health Ltd. enter into a strategic relationship to increase legal psychedelic therapy access for military veterans in North America (press release, October 2020)
- Field Trip Adds Acclaimed Physician, Dr. Andrew Weil, to Medical Advisory Board (press release, October 2020)
- Field Trip Health, Another Psychedelic Therapy Company, Goes Public (Forbes, October 2020)
- Field Trip Health Ltd. Completes Reverse Take-Over Transaction and Prepares for Listing on the Canadian Securities Exchange (press release, October 2020)
- Field Trip Psychedelics Inc. Announces Successful GLP Synthesis, Results From Initial Preclinical Testing for FT-104, its First Molecule in Development (press release, September 2020)
- Newton Energy Corporation Announces Definitive Agreement with Field Trip Psychedelics Inc. (press release, August 2020)
- Field Trip Psychedelics Inc. Announces Closing of $11.0 million Financing, Entry into Amalgamation Agreement with Newton Energy Corporation (press release, August 2020)
- On Your Next Psychedelic Journey, Let an App Be Your Guide (WIRED, August 2020)
- Guided ketamine trip therapy clinic opening in NYC this month (NYPost, August 2020)
- ‘Canada’s first psychedelic-enhanced psychotherapy centre’ changing how we treat depression (Global News, June 2020)
- Toronto’s first psychedelic therapy clinic is open. We gave it a try (Now Toronto, May 2020)
- Interview with Ronan Levy, Founder of Field Trip Health (Psilocybin Alpha, April 2020)
- Field Trip Psychedelics Inc. Announces Closing of Oversubscribed Series A Financing (press release, February 2020)
- A shroom field trip to nowhere? (Science Line, January 2020)
- The world’s first magic mushroom research center is launching in Jamaica (Quartz, September 2019)
Activities
B2B
B2C
Drug Discovery
Clinic
Topics of Interest
Depression
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates
Related Course(s)
DB101: How to Use Psychedelics to HealDB101: How to Use Psychedelics is a comprehensive course that covers everything you need to know to get the most out of your journey with these powerful medicines, including how to choose the right psychedelic for you, where to access safe, legal psychedelics, and how to integrate the lessons of your trip once it’s over.
Company News
Field Trip Health Ltd. Announces Intention to Separate the Field Trip Discovery and Field Trip Health Divisions Into Two Independent Public Companies (GlobeNewswire, 28 May 2022)The Future of Psychedelic Medicine Will Be Drugs You’ve Never Heard Of (Motherboard, 24 January 2022)
This article, by the always excellent Shayla Love, discussed the next generation of novel psychedelics. Starting with the many discoveries of Sasha Shulgin, the article then dives deeper into the wishes and hopes of psychedelic companies.